Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis

Overview of attention for article published in Frontiers in oncology, October 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 14,043 followers.

🏅 Review article #3: Recombinant Human Adenovirus-p53 Therapy for the Treatment of #CervicalCancer: A #MetaAnalysis Authors: Guo Y, Chen J et al 👉 https://t.co/uBifhsHwU6 @MedicalXuzhou #CervicalHealthMonth #p53 #CancerTreatments

05 Jan 2022

Reply Repost Favourite

INPLASY202150058 - Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis https://t.co/YVNrRHVC5U

19 Oct 2021

Reply Repost Favourite

RT @FrontOncology: New research: Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis: Objectives…

18 Oct 2021

Reply Repost Favourite

New research: Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis: Objectives To evaluate the clinical curative effects and toxicity of recombinant human adenovirus-p53 injection (rAd-p53) plus… https://t.co/Ajq59

18 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.